BRII-835

· Brii Biosciences Limited

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for BRII-835, covering 2024-06-18 to 2026-07-23. Get the full timeline:

Most recent: Clinical Trial Results: Study to Investigate the Safety and Efficacy of BRII-835 and BRII-179 Combination Therapy Treating Chronic Hepatitis B Virus (HBV) Infection [Phase 2]

See pricing